Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Irons

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Assay of protein S in systemic lupus erythematosusA S Lawrie, M E Lloyd, F Mohamed, et al.
The New England Journal of Medicine|November 18, 1976
Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergyW J Metzger, R Patterson, R Zeiss, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 6, 2021
Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based CohortD Ksienski, P T Truong, E S Wai, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumabA T Freeman, M Lesperance, E S Wai, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Assay of protein S in systemic lupus erythematosusA S Lawrie, M E Lloyd, F Mohamed, et al.
The New England Journal of Medicine|November 18, 1976
Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergyW J Metzger, R Patterson, R Zeiss, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 6, 2021
Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based CohortD Ksienski, P T Truong, E S Wai, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumabA T Freeman, M Lesperance, E S Wai, et al.
Pageof 2